Intellia Therapeutics (NTLA)

Intellia Therapeutics (NTLA) – FDA

Mar 18, 2024 07:36 AM Intellia Therapeutics (NTLA) doses first patient in Phase 3 MAGNITUDE Study of NTLA-2001
Feb 15, 2024 07:34 AM Intellia Therapeutics (NTLA) and ReCode Therapeutics Announce Strategic Collaboration to Develop Novel Gene Editing Therapies for Cystic Fibrosis
Jan 31, 2024 05:00 PM
Nov 14, 2023 07:31 AM
Nov 2, 2023 07:03 AM
Oct 18, 2023 07:02 AM
Oct 13, 2023 08:40 AM
Oct 3, 2023 07:02 AM
Jun 12, 2023 05:24 AM
May 31, 2023 07:41 AM
Mar 21, 2023 07:32 AM
Mar 2, 2023 07:01 AM
Jan 11, 2023 07:30 AM
Sep 16, 2022 07:16 AM
Sep 16, 2022 07:02 AM
Sep 1, 2022 04:01 PM
Jun 24, 2022 07:31 AM
May 2, 2022 07:31 AM
Mar 9, 2022 04:01 PM
Mar 9, 2022 11:47 AM
Feb 28, 2022 04:02 PM
Jan 7, 2022 06:25 AM
Jan 5, 2022 10:27 AM
Nov 22, 2021 07:32 AM
Oct 21, 2021 07:30 AM
Oct 20, 2021 07:31 AM
Oct 13, 2021 07:02 AM
Sep 16, 2021 07:31 AM
Jun 28, 2021 08:59 AM
Jun 28, 2021 06:08 AM
Jun 4, 2021 07:31 AM
Mar 30, 2021 07:32 AM
Mar 10, 2021 07:31 AM
Sep 29, 2020 08:20 AM
Mar 31, 2020 07:38 AM
Feb 10, 2020 07:30 AM
Oct 18, 2018 08:33 AM
Aug 9, 2018 12:59 PM
Jul 16, 2018 11:05 AM
Jun 11, 2018 11:10 AM
May 14, 2018 07:32 AM
Feb 27, 2018 09:31 AM
Jun 6, 2017 07:17 AM
May 15, 2017 05:47 AM
Mar 8, 2017 07:36 AM
Dec 16, 2016 08:05 AM
Aug 22, 2016 08:35 AM
Aug 5, 2016 07:14 AM